Dr Annie Chow

Clinical Haematologist
Become a Patient

Dr Annie Chow takes a measured and empathetic approach to caring for her patients. She brings a wealth of experience to her practice and helps her patients every step of the way, navigating often complex issues.


Dr Annie Chow is a clinical haematologist at Icon Cancer Centre Adelaide. In 2003, she completed her Bachelor of Medicine and Bachelor of Surgery (MBBS) with honours at the University of Western Australia before commencing specialist training in Perth and Adelaide.

Dr Chow completed a clinical research fellowship at Royal Adelaide Hospital where she developed a strong interest in the management and treatment of multiple myeloma. She subsequently completed a multiple myeloma fellowship at the Australian Centre of Blood Disease and the Alfred Hospital, Melbourne, where she worked extensively in laboratory and clinical research.

Dr Chow is experienced in caring for a wide range of malignant and non-malignant haematological conditions. She is a fellow of the Royal Australasian College of Physicians (FRACP) and Royal College of Pathologists of Australasia (FRCPA).

Affiliations & Memberships

  • Royal Australasian College of Physicians (RACP)
  • Royal College of Pathologist of Australasia (RCPA)

Special Interests

Dr Annie Chow accepts referrals for malignant and non-malignant blood disorders.
  • Haematology

Icon Locations

Adelaide (Kurralta Park) View centre


  • Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myeloma. Mithraprabhu S, Khong T, Ramachandran M, Chow A, Klarica D, Mai L, Walsh S, Broemeling D, Marziali A, Wiggin M, Hocking J, Kalff A, Durie B, Spencer A.Leukemia, 2017 Aug;31(8):1695-1705. 

  • Circulating N-cadherin levels are a negative prognostic indicator in patients with multiple myeloma. K. Vandyke, A. Chow, S. Williams, B. To & A. Zannettino. British Journal of Haematology, 2013; 161(4): 499-507.

  • Alpha thalassaemia due to non-deletional mutations on the -3.7 alpha globin fusion gene: laboratory diagnosis and clinical importance. Chow A, Ghassemifar R, Finlayson J.Pathology, 2013 Oct;45(6):591-4.

  • Relapsed myeloma: who benefits from salvage autografts? A. Chow, C. Lee, D. Hiwase, N. Horvath & L.N. To. Journal of Internal Medicine, 2013; 43(2): 156-61.

  • Prognostic nomogram for diffuse large B cell lymphoma incorporating the International Prognostic Index with interim-PET findings. A. Chow, M. Phillips. T. Siew, G. Cull, B. Augustson, M. Ward & D. Joske. Journal of Internal Medicine, 2013; 43(8): 932-9.